Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Lymphoma 112Lymphoma, Large B-Cell, Diffuse 77Precursor Cell Lymphoblastic Leukemia-Lymphoma 67Leukemia 47Burkitt Lymphoma 45Lymphoma, Non-Hodgkin 35Lymphoma, Mantle-Cell 28Lymphoma, Follicular 27Hodgkin Disease 22Neuroblastoma 19Central Nervous System Neoplasms 19Sarcoma 18Lymphoma, B-Cell 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Large-Cell, Immunoblastic 12Lymphoma, T-Cell, Peripheral 11Lymphoma, Large-Cell, Anaplastic 11Neoplasms 10Multiple Myeloma 10Dendritic Cell Sarcoma, Interdigitating 10Sarcoma, Ewing 9Rhabdomyosarcoma 9Retinoblastoma 9Medulloblastoma 9Lymphoma, B-Cell, Marginal Zone 8Leukemia, Biphenotypic, Acute 8Recurrence 7Neuroectodermal Tumors, Primitive, Peripheral 7Lymphoma, T-Cell 7HIV Infections 7

Interventions

Vincristine 2Methotrexate 2Mercaptopurine 2Hydrocortisone 2Cytarabine 2prednylidene 1pegaspargase 1merphos 1hydrocortisone hemisuccinate 1dexamethasone acetate 1dexamethasone 21-phosphate 1calaspargase pegol 1blinatumomab 1azathiopurine 1auricularum 1Spinal Puncture 1Specimen Handling 1Radiotherapy, Conformal 1Prednisolone 1Nivolumab 1N,N-dicyclohexyl-isoborneol-10-sulfonamide 1Epirubicin 1Dexamethasone 1Daunorubicin 1Cyclophosphamide 1Calcium Dobesilate 1Biopsy 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Down Syndrome × Vincristine × Clear all
NCT03286634 2026-05-11

ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016

National Hospital Organization Nagoya Medical Center

Phase 2 Active not recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Down Syndrome, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04546399 2025-09-10

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

National Cancer Institute (NCI)

Phase 2 Recruiting
461 enrolled
Lymphoid

Burkitt Lymphoma, Down Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡